Endoscopic Devices - Southeast Asia

Revenue in the Endoscopic Devices market market in Southeast Asia is anticipated to reach US$695.50m in 2024.
This revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 8.62%, which will lead to a market volume of US$1.05bn by 2029.
In a global context, the majority of revenue is projected to be generated the United States, with figures amounting to US$10.39bn in 2024.
The endoscopic devices market in Southeast Asia is experiencing significant growth as hospitals increasingly adopt minimally invasive surgical techniques to enhance patient outcomes.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Southeast Asia is witnessing moderate growth, influenced by factors such as increasing prevalence of gastrointestinal diseases, advancements in minimally invasive procedures, and growing healthcare investments in the region.

Customer preferences: Consumers in Southeast Asia are increasingly prioritizing early diagnosis and preventive healthcare, significantly impacting the Endoscopic Devices Market. This shift is driven by rising health awareness and a growing emphasis on wellness, particularly among younger demographics. Additionally, cultural attitudes favoring traditional and holistic approaches are evolving, leading to greater acceptance of advanced medical technologies. As lifestyles become more fast-paced, there is a marked preference for minimally invasive procedures, enhancing patient comfort and recovery times, thereby driving demand for innovative endoscopic solutions.

Trends in the market: In Southeast Asia, the Endoscopic Devices Market is experiencing a surge in demand for advanced imaging technologies, as healthcare providers increasingly adopt enhanced visualization tools for diagnostics and procedures. Concurrently, there is a growing trend toward integrating artificial intelligence in endoscopic procedures, improving accuracy and efficiency. The focus on outpatient care is amplifying the preference for minimally invasive techniques, reducing hospital stays and recovery times. These trends are significant, creating opportunities for industry stakeholders to innovate and expand their offerings in a rapidly evolving healthcare landscape.

Local special circumstances: In Southeast Asia, the Endoscopic Devices Market is shaped by diverse cultural attitudes toward healthcare, with a strong emphasis on traditional medicine influencing patient preferences. The region's varied geographical landscape results in disparities in healthcare access, prompting a shift toward mobile and accessible endoscopic solutions. Additionally, regulatory frameworks differ significantly across countries, impacting the speed of technology adoption. These unique local factors drive demand for tailored endoscopic devices that align with both modern medical practices and cultural sensitivities, fostering innovation in the market.

Underlying macroeconomic factors: The Endoscopic Devices Market in Southeast Asia is significantly influenced by macroeconomic factors such as economic growth, healthcare spending, and investment in medical technology. As national economies expand, increased healthcare budgets are facilitating the adoption of advanced endoscopic devices, enhancing diagnostic and therapeutic capabilities. Furthermore, rising disposable incomes lead to greater patient demand for minimally invasive procedures, driving market growth. Regulatory support and streamlined approval processes are crucial for accelerating technology adoption. Additionally, the growing prevalence of gastrointestinal disorders in the region underscores the need for innovative endoscopic solutions, further propelling market performance.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.